Back to search

Article

Divergent Minimum Inhibitory Concentrations of Clarithromycin and Azithromycin Against Clinical Isolates of <i>Mycobacterium abscessus</i> Complex

2025-05-14

Abstract excerpt

<h4>ABSTRACT</h4> Current treatment guidelines for Mycobacterium abscessus complex (MAB) infections recommend macrolides (clarithromycin/CAM and azithromycin/AZM) as cornerstone therapies, considering them clinically interchangeable without distinction. This study evaluated the comparative in vitro activity of clarithromycin (CAM) and azithromycin (AZM) against 146 clinical isolates of Mycobacterium abscessus c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec3455ef-c9fc-55cf-839a-8e680c68dd0d
DOI
10.1101/2025.05.14.654039
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Divergent Minimum Inhibitory Concentrations of Clarithromycin and Azithromycin Against Clinical Isolates of <i>Mycobacterium abscessus</i> ComplexDOI 10.1101/2025.05.14.654039
Select a neighboring publication to make it the new centre.